LON:INS - Instem Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 323 0.00 (0.00 %)
(As of 02/15/2019 04:00 PM ET)
Previous CloseGBX 323
Today's RangeGBX 328.60 - GBX 328.60
52-Week RangeGBX 140 - GBX 235.99
Volume181 shs
Average Volume3,909 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Instem plc provides information technology solutions to the life science market worldwide. The company offers solutions for data collection, management, and analysis to meet the needs of life science and healthcare organizations for data-driven decision making. Its solutions include Provantis, an integrated Windows-based system for organizations and universities that are engaged in non-clinical evaluation studies; submit platform that provides a suite of integrated tools and services for the creation and management of SEND datasets and associated documents for contract research organizations and sponsors; ALPHADAS, an eSource EDC system for early phase clinical trials; Animal Care Information System, an animal management software solution; Logbook, a repository for information; and Toxicology Resource Planning, a toxicology solution for pharmaceutical, chemical, and contract research laboratory corporations. The company also provides Comet Assay IV, a live video imaging system for reproducible comet slide scoring; and Sorcerer Colony Counter for automatic plate counter; Cyto Study Manager, a data acquisition and reporting solution; Ames Study Manager, plate countiner; Sorcerer Colony Counter for automatic plate counter; NOTOCORD-hem and NOTOCORD-fps software platforms to acquire, display, and analyze physiological signals; SEND Explorer, a Web-based application with optional data warehousing capabilities; and SRS data integration platform. It also provides data management, cloud, safety assessment, regulatory information management, solution deployment, and validation services. Additionally, it provides software solutions for extracting intelligence from research and development related healthcare data; and develops, manufactures, and supplies software and hardware products for in vitro study data collection and study management. Instem plc was founded in 1969 and is headquartered in Stone, the United Kingdom.

Receive INS News and Ratings via Email

Sign-up to receive the latest news and ratings for INS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Healthcare Information Services
SectorComputer and Technology



Sales & Book Value

Annual SalesN/A



OptionableNot Optionable

Instem (LON:INS) Frequently Asked Questions

What is Instem's stock symbol?

Instem trades on the London Stock Exchange (LON) under the ticker symbol "INS."

Has Instem been receiving favorable news coverage?

News coverage about INS stock has been trending somewhat negative recently, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Instem earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days.

Who are some of Instem's key competitors?

Who are Instem's key executives?

Instem's management team includes the folowing people:
  • Mr. Phil J. Reason, CEO & Exec. Director (Age 57)
  • Mr. Nigel John Goldsmith, CFO, Sec. & Exec. Director (Age 57)
  • Ms. Marybeth Thompson, Chief Operating Officer
  • Dr. Gordon Smith Baxter Ph.D., Chief Scientific Officer
  • Ms. Jennifer Feldmann, VP of Bus. Devel.

How do I buy shares of Instem?

Shares of INS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Instem's stock price today?

One share of INS stock can currently be purchased for approximately GBX 323.

What is Instem's official website?

The official website for Instem is http://www.instem.com/.

How can I contact Instem?

Instem's mailing address is Diamond Way, Stone Business Park, STONE, ST15 0SD, United Kingdom. The company can be reached via phone at +44-1785-825600.

MarketBeat Community Rating for Instem (LON INS)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  74 (Vote Outperform)
Underperform Votes:  157 (Vote Underperform)
Total Votes:  231
MarketBeat's community ratings are surveys of what our community members think about Instem and other stocks. Vote "Outperform" if you believe INS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel